Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

Alberto Fresa; Francesco Autore; Alfonso Piciocchi; Gioacchino Catania; Andrea Visentin; Annamaria Tomasso; Marina Moretti; Candida Vitale; Annalisa Chiarenza; Francesca Morelli; Paolo Sportoletti; Roberto Marasca; Giuseppe Sapienza; Annarosa Cuccaro; Roberta Murru; Alessandro Sanna; Caterina Patti; Ilaria Angeletti; Marta Coscia; Livio Trentin; Daniela Pietrasanta; Idanna Innocenti; Luca Laurenti

doi:10.1182/bloodadvances.2022006964

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

Alberto Fresa, Francesco Autore, Alfonso Piciocchi, Gioacchino Catania, Andrea Visentin, Annamaria Tomasso, Marina Moretti, Candida Vitale, Annalisa Chiarenza, Francesca Morelli, Paolo Sportoletti, Roberto Marasca, Giuseppe Sapienza, Annarosa Cuccaro, Roberta Murru, Alessandro Sanna, Caterina Patti, Ilaria Angeletti, Marta Coscia, Livio TrentinDaniela Pietrasanta, Idanna Innocenti, Luca Laurenti

Research output: Contribution to journal › Article

Abstract

N/A

Original language	English
Pages (from-to)	3875-3878
Number of pages	4
Journal	Blood advances
Volume	6
DOIs	https://doi.org/10.1182/bloodadvances.2022006964
Publication status	Published - 2022

Keywords

n/a

Access to Document

10.1182/bloodadvances.2022006964

Cite this

Fresa, A., Autore, F., Piciocchi, A., Catania, G., Visentin, A., Tomasso, A., Moretti, M., Vitale, C., Chiarenza, A., Morelli, F., Sportoletti, P., Marasca, R., Sapienza, G., Cuccaro, A., Murru, R., Sanna, A., Patti, C., Angeletti, I., Coscia, M., ... Laurenti, L. (2022). Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood advances, 6, 3875-3878. https://doi.org/10.1182/bloodadvances.2022006964

@article{f56eca86e2ee436c8ff27b86ddc572d1,

title = "Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study",

abstract = "N/A",

keywords = "n/a, n/a",

author = "Alberto Fresa and Francesco Autore and Alfonso Piciocchi and Gioacchino Catania and Andrea Visentin and Annamaria Tomasso and Marina Moretti and Candida Vitale and Annalisa Chiarenza and Francesca Morelli and Paolo Sportoletti and Roberto Marasca and Giuseppe Sapienza and Annarosa Cuccaro and Roberta Murru and Alessandro Sanna and Caterina Patti and Ilaria Angeletti and Marta Coscia and Livio Trentin and Daniela Pietrasanta and Idanna Innocenti and Luca Laurenti",

year = "2022",

doi = "10.1182/bloodadvances.2022006964",

language = "English",

volume = "6",

pages = "3875--3878",

journal = "Blood advances",

issn = "2473-9537",

publisher = "American Society of Hematology",

}

Fresa, A, Autore, F, Piciocchi, A, Catania, G, Visentin, A, Tomasso, A, Moretti, M, Vitale, C, Chiarenza, A, Morelli, F, Sportoletti, P, Marasca, R, Sapienza, G, Cuccaro, A, Murru, R, Sanna, A, Patti, C, Angeletti, I, Coscia, M, Trentin, L, Pietrasanta, D, Innocenti, I & Laurenti, L 2022, 'Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study', Blood advances, vol. 6, pp. 3875-3878. https://doi.org/10.1182/bloodadvances.2022006964

TY - JOUR

T1 - Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

AU - Fresa, Alberto

AU - Autore, Francesco

AU - Piciocchi, Alfonso

AU - Catania, Gioacchino

AU - Visentin, Andrea

AU - Tomasso, Annamaria

AU - Moretti, Marina

AU - Vitale, Candida

AU - Chiarenza, Annalisa

AU - Morelli, Francesca

AU - Sportoletti, Paolo

AU - Marasca, Roberto

AU - Sapienza, Giuseppe

AU - Cuccaro, Annarosa

AU - Murru, Roberta

AU - Sanna, Alessandro

AU - Patti, Caterina

AU - Angeletti, Ilaria

AU - Coscia, Marta

AU - Trentin, Livio

AU - Pietrasanta, Daniela

AU - Innocenti, Idanna

AU - Laurenti, Luca

PY - 2022

Y1 - 2022

N2 - N/A

AB - N/A

KW - n/a

UR - http://hdl.handle.net/10807/232173

U2 - 10.1182/bloodadvances.2022006964

DO - 10.1182/bloodadvances.2022006964

M3 - Article

SN - 2473-9537

VL - 6

SP - 3875

EP - 3878

JO - Blood advances

JF - Blood advances

ER -

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this